Keywords: sandoz, alzheimer, drug, international, data, revealed, reported

Sandoz' Alzheimer's Drug; International Data Revealed

Article | 02 December 1996

Sandoz has reported confirmatory clinical data from its ADENA clinical trials program for Exelon (ENA-713), a new-generation acetylcholinesterase inhibitor for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Sandoz

Eisai

Go to company listing

Related Drugs

Rivastigmine Tartrate

Exelon

Cognex

Tacrine

Testosterone

Go to drug listing